Prometheus Biosciences Inc

+0.30 (+1.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.05B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.2 Million
Adjusted EPS-$0.39
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Prometheus Biosciences Inc Stock, NASDAQ:RXDX

9410 Carroll Park Drive, San Diego, California 92121
United States of America
Phone: +1.858.824.0895
Number of Employees: 27


Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .